1 – 10 of 344
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
- Study of hepatitis E virus infection of genotype 1 and 3 in mice with humanised liver
- Metabolic studies of prostanozol with the uPA-SCID chimeric mouse model and human liver microsomes
- A monoclonal antibody-based immunoassay to measure the antibody response against the repeat region of the circumsporozoite protein of Plasmodium falciparum
- Monoclonal anti-envelope antibody AP33 protects humanized mice against a patient-derived hepatitis C virus challenge
- In vitro and in vivo metabolism studies of dimethazine
- Targeting a host-cell entry factor barricades antiviral-resistant HCV variants from on-therapy breakthrough in human-liver mice
- 2015
- Assessment of parasite liver-stage burden in human-liver chimeric mice
- Old and new adjuvants for hepatitis B vaccines
- Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS-21 induce strong humoral and cellular immune responses against hepatitis B surface antigen which persist for at least 4 years after vaccination
- Anti-CD81 but not anti-SR-BI blocks Plasmodium falciparum liver infection in a humanized mouse model